PhytoNexus

PhytoNexus

Department of Pharmacognosy · Herb-Drug Interaction Intelligence Platform · generated 27 Jul 2026 02:42 IST
Papaveraceae · source entry 178

Sanguinaria canadensis

Bloodroot

Tier 2 · Verified 0 curated · 2 predicted 4Contraindicated Risk index 64.8
Interaction profile
DELAY OF EFFECTIVE TREATMENT - HARM IS AS MUCH FROM FORGONE EFFE

01 Identity and provenance

Accepted binomial
Sanguinaria canadensis
Common names
Bloodroot
Family (APG IV)
Papaveraceae
Part used
Rhizome
Verification tier
Tier 2 · Verified Clinical columns reviewed and a source is on record.
Reviewer note (2026 audit)
Croaker A et al. Mutat Res 2017;774:46-56 (carcinogenic potential of sanguinarine) | McDaniel S & Goldman GD. Arch Dermatol 2002;138:1593-6 | VERIFIED 2026 (batch 3) - synthetic analogue, application, interactions, side effects and references populated from retrieved primary/regulatory sources. Interactions labelled CLINICAL vs THEORETICAL. Marketed-formulation column intentionally blank. | CARE PATHWAY

02 Constituent chemistry

Chemical classMarker compoundSynthetic analogue in use
Benzophenanthridine alkaloids Sanguinarine
Rhizome
No legitimate analogue. Escharotic action is non-selective chemical cauterisation, not targeted therapy.

The analogue column is what makes the interaction reasoning tractable: where a constituent has a marketed structural counterpart, the counterpart's interaction profile is the starting hypothesis for the plant.

Looking up structures and physicochemical properties from PubChem…

03 Stated application

Reported activity
NO ACCEPTED USE. Historically an escharotic in "black salve". FDA lists black salve as a fake cancer cure; such products are no longer legally marketable in the US. Sanguinarine-containing mouthwash was withdrawn.
Reported adverse effects
PERMANENT DISFIGUREMENT AND DEATH. Sanguinarine plus zinc chloride causes coagulative necrosis indiscriminately in malignant AND healthy tissue; the in-vitro selectivity does not hold at the variable doses in unregulated products. FDA has identified 24 adverse-event cases (15 in the preceding five years), mostly permanent damage and cancer progression, with at least one death in someone who used salve instead of proven therapy. Reported: complete destruction of the nasal ala, metastatic recurrence 11 years later. Tumour may appear to resolve while continuing to grow beneath the eschar. Sanguinarine is a DNA intercalator structurally similar to polyaromatic hydrocarbon carcinogens; bloodroot mouthwash was epidemiologically linked to dysplastic leukoplakia. SOLD UNDER MANY NAMES: Cansema, Skinprov, drawing salve, red salve, Indian Herb, Black Drawing Ointment.

04 Interaction matrix

Source column, verbatim: Not applicable - the harm is direct tissue destruction and, critically, DELAY OF EFFECTIVE TREATMENT.
Normalised onto 0 canonical drug classes below.

Predicted from constituent chemistry

These edges are not clinical findings. Each one is a rule inference: a constituent class in this plant is known to act on a target that the drug class also acts on. They are shown because a blank cell reads as “safe”, and for a Tier 1 entry a blank cell only means “not yet looked at”. Treat them as a literature-search agenda, not as a warning.
Drug classSeverityMechanism type ProvenanceExpected effect
Narrow-therapeutic-index CYP3A4 substrates
Pharmacokinetic
4Contraindicated PK-CYP3A4 predicted D Toxic accumulation or subtherapeutic failure of the co-prescribed drug, s… why ▾
Antacids, PPIs and H2 blockers
Gastrointestinal
2Moderate PK-absorption predicted D Reduced or erratic absorption of alkaloids; heartburn and reflux from pre… why ▾

05 Hazard register

delay of effective treatment - harm is as much from forgone effe

06 Confusable material

No same-genus or shared-common-name entry in the corpus.

07 Mechanism map

Chemistry sorts to the left, pharmacology to the right. Dashed edges are predicted. Drag nodes, scroll to zoom, export at 3× for a figure.

species
chemical class
marker compound
drug class
expected effect
hazard

08 Open literature

Abstract-scoped query built from this binomial, its common names and its marker compounds, run live against Europe PMC, PubMed and OpenAlex, then ranked locally against an evidence hierarchy.

Checking openFDA spontaneous reports…

09 Isomechanistic neighbours

Species whose interaction profile overlaps this one, ranked by shared severity weight rather than by count — a shared contraindication counts for more than a shared minor signal. Practical use: these are the plants you should not stack with this one, because the mechanisms summate.

SpeciesFamilyShared classes WeightJaccard
Holarrhena pubescens
Kurchi
Apocynaceae 2 1.00
Sida cordifolia
Bala
Malvaceae 2 1.00
Solanum virginianum
Kantakari
Solanaceae 2 1.00
Tylophora indica
Antamul
Apocynaceae 2 1.00
Carica papaya
Papaya
Caricaceae 2 1.00
Morus alba
Mulberry
Moraceae 2 1.00

10 References and notes

Source column: FDA consumer update: black salve is dangerous and has many names

FDA consumer update: black salve is dangerous and has many names

manual
BibTeX for all 1 records
@article{anon,
  title = {FDA consumer update: black salve is dangerous and has many names},
}

Curator notes

No notes yet.

Sign in to add notes and save monographs.